Post-treatment Follow-Up, Surveillance, and Prevention Strategies in Hydatid Disease
Küçük Resim Yok
Tarih
2025
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Springer Science+Business Media
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Hydatid disease, also known as hydatidosis or echinococcosis, caused by Echinococcus species, requires structured follow-up to prevent recurrence and manage complications. Treatment options include surgery, radiological intervention, medical therapy and wait and watch, each necessitating a specific post-treatment surveillance approach. Imaging modalities such as ultrasonography, computed tomography, and magnetic resonance imaging are essential for monitoring disease progression, while serological tests, particularly enzyme-linked immunosorbent assay and indirect hemagglutination, aid in assessing therapeutic response. However, in immunosuppressed patients, standard serological tests may yield false-negative results, making Western blot a more reliable alternative. For patients undergoing liver transplantation due to alveolar echinococcosis, long-term monitoring is crucial to prevent disease recurrence and optimize immunosuppressive therapy. While some centers do not routinely use anthelmintic benzimidazoles post-transplant, most recommend their administration for up to 2 years to minimize recurrence risk. A multidisciplinary approach incorporating radiology, serology, and clinical assessment is key to achieving optimal long-term outcomes. This chapter presents structured follow-up protocols and highlights best practices in hydatid disease surveillance to enhance patient management and prognosis. © 2025 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG.
Açıklama
Anahtar Kelimeler
Follow-up, Hydatid disease, Imaging modalities, Liver transplantation, Prevention, Serological monitoring, Surveillance
Kaynak
Hydatid Disease: Diagnosis, Treatment and Follow Up Strategies
WoS Q Değeri
Scopus Q Değeri
N/A
